{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:22:15Z","timestamp":1791303735362,"version":"4.1.0"},"reference-count":180,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001703","name":"\u00c9cole Polytechnique F\u00e9d\u00e9rale de Lausanne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001703","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.nbd.2011.07.001","type":"journal-article","created":{"date-parts":[[2011,7,16]],"date-time":"2011-07-16T04:10:00Z","timestamp":1310789400000},"page":"83-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":138,"title":["What have we learned from gene expression profiles in Huntington's disease?"],"prefix":"10.1016","volume":"45","author":[{"given":"Tamara","family":"Seredenina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Luthi-Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2011.07.001_bb0005","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1755-5949.2010.00134.x","article-title":"Dopamine and glutamate in Huntington's disease: a balancing act","volume":"16","author":"Andre","year":"2010","journal-title":"CNS Neurosci. Ther."},{"issue":"Pt 6","key":"10.1016\/j.nbd.2011.07.001_bb0010","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1093\/brain\/119.6.2085","article-title":"Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease","volume":"119","author":"Antonini","year":"1996","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2011.07.001_bb0015","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/hmg\/ddi443","article-title":"Mutant huntingtin alters MAPK signaling pathways in PC12 and striatal cells: ERK1\/2 protects against mutant huntingtin-associated toxicity","volume":"15","author":"Apostol","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.07.001_bb0020","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1523\/JNEUROSCI.2986-07.2008","article-title":"Ctip2 controls the differentiation of medium spiny neurons and the establishment of the cellular architecture of the striatum","volume":"28","author":"Arlotta","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.07.001_bb0025","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10048-004-0198-8","article-title":"NR2A and NR2B receptor gene variations modify age at onset in Huntington disease","volume":"6","author":"Arning","year":"2005","journal-title":"Neurogenetics"},{"key":"10.1016\/j.nbd.2011.07.001_bb0030","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/ana.410420213","article-title":"Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease","volume":"42","author":"Augood","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2011.07.001_bb0035","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1042\/bj20020496","article-title":"COUP-TF (chicken ovalbumin upstream promoter transcription factor)-interacting protein 1 (CTIP1) is a sequence-specific DNA binding protein","volume":"368","author":"Avram","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.nbd.2011.07.001_bb0895","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuron.2005.06.005","article-title":"p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease","volume":"47","author":"Bae","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2011.07.001_bb0040","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrn1386","article-title":"Experimental therapeutics in transgenic mouse models of Huntington's disease","volume":"5","author":"Beal","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2011.07.001_bb0045","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/hmg\/ddq018","article-title":"Transcriptional changes in Huntington disease identified using genome-wide expression profiling and cross-platform analysis","volume":"19","author":"Becanovic","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.07.001_bb0050","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1093\/hmg\/ddi340","article-title":"Contribution of nuclear and extranuclear polyQ to neurological phenotypes in mouse models of Huntington's disease","volume":"14","author":"Benn","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.07.001_bb0055","doi-asserted-by":"crossref","first-page":"10720","DOI":"10.1523\/JNEUROSCI.2126-08.2008","article-title":"Huntingtin modulates transcription, occupies gene promoters in vivo, and binds directly to DNA in a polyglutamine-dependent manner","volume":"28","author":"Benn","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.07.001_bb0900","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/NEN.0b013e3181ea167f","article-title":"Environmental enrichment reduces neuronal intranuclear inclusion load but has no effect on messenger RNA expression in a mouse model of Huntington disease","volume":"69","author":"Benn","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.07.001_bb0060","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.4161\/cc.5.24.3579","article-title":"A new role for microRNA pathways: modulation of degeneration induced by pathogenic human disease proteins","volume":"5","author":"Bilen","year":"2006","journal-title":"Cell Cycle."},{"key":"10.1016\/j.nbd.2011.07.001_bb0065","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/brain\/awq278","article-title":"Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease","volume":"134","author":"Blazquez","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2011.07.001_bb0070","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1523\/JNEUROSCI.23-12-05361.2003","article-title":"A dual role of adenosine A2A receptors in 3-nitropropionic acid-induced striatal lesions: implications for the neuroprotective potential of A2A antagonists","volume":"23","author":"Blum","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.07.001_bb0075","doi-asserted-by":"crossref","first-page":"11023","DOI":"10.1073\/pnas.0504921102","article-title":"Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease","volume":"102","author":"Borovecki","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.07.001_bb0080","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/mt.2009.17","article-title":"Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice","volume":"17","author":"Boudreau","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2011.07.001_bb0085","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/hmg\/8.9.1647","article-title":"Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin","volume":"8","author":"Boutell","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.07.001_bb0090","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1093\/hmg\/ddn206","article-title":"Neocortical expression of mutant huntingtin is not required for alterations in striatal gene expression or motor dysfunction in a transgenic mouse","volume":"17","author":"Brown","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.07.001_bb0095","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/nrn1989","article-title":"Histone deacetylase inhibitors as therapeutics for polyglutamine disorders","volume":"7","author":"Butler","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2011.07.001_bb0100","doi-asserted-by":"crossref","first-page":"33791","DOI":"10.1074\/jbc.M204861200","article-title":"Glycogen synthase kinase-3beta inhibitors prevent cellular polyglutamine toxicity caused by the Huntington's disease mutation","volume":"277","author":"Carmichael","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.07.001_bb0105","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nrn1806","article-title":"Normal huntingtin function: an alternative approach to Huntington's disease","volume":"6","author":"Cattaneo","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2011.07.001_bb0110","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/jnr.20344","article-title":"Increased GABAergic function in mouse models of Huntington's disease: reversal by BDNF","volume":"78","author":"Cepeda","year":"2004","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2011.07.001_bb0115","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.pneurobio.2007.03.004","article-title":"Transcriptional signatures in Huntington's disease","volume":"83","author":"Cha","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2011.07.001_bb0120","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1098\/rstb.1999.0449","article-title":"Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease","volume":"354","author":"Cha","year":"1999","journal-title":"Philos. Trans. R. Soc. Lond. B. Biol. Sci."},{"key":"10.1016\/j.nbd.2011.07.001_bb0125","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1093\/hmg\/11.17.1939","article-title":"Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease","volume":"11","author":"Chan","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.07.001_bb0130","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1093\/hmg\/ddp243","article-title":"Impaired PGC-1alpha function in muscle in Huntington's disease","volume":"18","author":"Chaturvedi","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.07.001_bb0135","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.nbd.2005.11.001","article-title":"Decreased association of the transcription factor Sp1 with genes downregulated in Huntington's disease","volume":"22","author":"Chen-Plotkin","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.07.001_bb0140","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.nbd.2008.03.011","article-title":"Polyglutamine-expanded ataxin-3 causes cerebellar dysfunction of SCA3 transgenic mice by inducing transcriptional dysregulation","volume":"31","author":"Chou","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.07.001_bb0145","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.mcn.2005.05.003","article-title":"Mutant huntingtin represses CBP, but not p300, by binding and protein degradation","volume":"30","author":"Cong","year":"2005","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2011.07.001_bb0150","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/ng1503","article-title":"Polyglutamine expansion of huntingtin impairs its nuclear export","volume":"37","author":"Cornett","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2011.07.001_bb0155","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1093\/hmg\/ddq055","article-title":"CalDAG-GEFI down-regulation in the striatum as a neuroprotective change in Huntington's disease","volume":"19","author":"Crittenden","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.07.001_bb0160","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.brainres.2006.02.102","article-title":"DNA microarray analysis of striatal gene expression in symptomatic transgenic Huntington's mice (R6\/2) reveals neuroinflammation and insulin associations","volume":"1088","author":"Crocker","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2011.07.001_bb0165","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","author":"Cui","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2011.07.001_bb0170","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","article-title":"Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation","volume":"90","author":"Davies","year":"1997","journal-title":"Cell"},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2011.07.001_bb0175","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/1471-2091-8-S1-S2","article-title":"The ubiquitin proteasome system in Huntington's disease and the spinocerebellar ataxias","volume":"8","author":"Davies","year":"2007","journal-title":"BMC Biochem."},{"key":"10.1016\/j.nbd.2011.07.001_bb0180","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0306-4522(00)00157-3","article-title":"Cannabinoid receptor messenger RNA levels decrease in a subset of neurons of the lateral striatum, cortex and hippocampus of transgenic Huntington's disease mice","volume":"98","author":"Denovan-Wright","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2011.07.001_bb0185","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1471-4159.2005.03588.x","article-title":"Selective deficits in the expression of striatal-enriched mRNAs in Huntington's disease","volume":"96","author":"Desplats","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2011.07.001_bb0190","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.nbd.2008.05.005","article-title":"Functional roles for the striatal-enriched transcription factor, Bcl11b, in the control of striatal gene expression and transcriptional dysregulation in Huntington's disease","volume":"31","author":"Desplats","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.07.001_bb0195","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.nbd.2009.06.009","article-title":"A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease","volume":"35","author":"Dhaenens","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.07.001_bb0200","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.nbd.2011.07.001_bb0205","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ana.21569","article-title":"Sustained effects of nonallele-specific Huntingtin silencing","volume":"65","author":"Drouet","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2011.07.001_bb0210","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1126\/science.1072613","article-title":"Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease","volume":"296","author":"Dunah","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.nbd.2011.07.001_bb0215","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1128\/MCB.00128-07","article-title":"P-body formation is a consequence, not the cause, of RNA-mediated gene silencing","volume":"27","author":"Eulalio","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.nbd.2011.07.001_bb0220","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/hmg\/7.9.1463","article-title":"Huntingtin interacts with a family of WW domain proteins","volume":"7","author":"Faber","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.07.001_bb0225","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0248-4900(02)00006-0","article-title":"F3\/contactin, a neuronal cell adhesion molecule implicated in axogenesis and myelination","volume":"94","author":"Falk","year":"2002","journal-title":"Biol Cell."},{"key":"10.1016\/j.nbd.2011.07.001_bb0230","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1523\/JNEUROSCI.23-28-09418.2003","article-title":"Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice","volume":"23","author":"Ferrante","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.07.001_bb0235","doi-asserted-by":"crossref","first-page":"10335","DOI":"10.1523\/JNEUROSCI.2599-04.2004","article-title":"Chemotherapy for the brain: the antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington's disease","volume":"24","author":"Ferrante","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.07.001_bb0240","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.1523\/JNEUROSCI.13-12-05402.1993","article-title":"The striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain","volume":"13","author":"Ferre","year":"1993","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.07.001_bb0245","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1100\/tsw.2008.60","article-title":"The ubiquitin\u2013proteasome pathway in Huntington's disease","volume":"8","author":"Finkbeiner","year":"2008","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.nbd.2011.07.001_bb0250","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1136\/jmg.2009.066399","article-title":"Wild-type but not mutant huntingtin modulates the transcriptional activity of liver X receptors","volume":"46","author":"Futter","year":"2009","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.nbd.2011.07.001_bb0255","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1124\/jpet.110.167551","article-title":"Diminished activity-dependent brain-derived neurotrophic factor expression underlies cortical neuron microcircuit hypoconnectivity resulting from exposure to mutant huntingtin fragments","volume":"335","author":"Gambazzi","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2011.07.001_bb0260","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1074\/jbc.M410210200","article-title":"Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease","volume":"280","author":"Gardian","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.07.001_bb0265","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1471-4159.2007.05137.x","article-title":"Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington's disease phenotypes in mice","volume":"105","author":"Gharami","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2011.07.001_bb0270","doi-asserted-by":"crossref","first-page":"7390","DOI":"10.1074\/jbc.M708192200","article-title":"Histone deacetylase inhibition modulates kynurenine pathway activation in yeast, microglia, and mice expressing a mutant huntingtin fragment","volume":"283","author":"Giorgini","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.07.001_bb0275","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0306-4522(93)90352-G","article-title":"Loss of cannabinoid receptors in the substantia nigra in Huntington's disease","volume":"56","author":"Glass","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2011.07.001_bb0280","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1038\/emboj.2010.117","article-title":"Mutant huntingtin-impaired degradation of beta-catenin causes neurotoxicity in Huntington's disease","volume":"29","author":"Godin","year":"2010","journal-title":"EMBO J."},{"key":"10.1016\/j.nbd.2011.07.001_bb0285","doi-asserted-by":"crossref","first-page":"7617","DOI":"10.1128\/MCB.21.22.7617-7628.2001","article-title":"The transcription elongation factor CA150 interacts with RNA polymerase II and the pre-mRNA splicing factor SF1","volume":"21","author":"Goldstrohm","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.nbd.2011.07.001_bb0290","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.neuron.2008.09.002","article-title":"From synapse to nucleus: calcium-dependent gene transcription in the control of synapse development and function","volume":"59","author":"Greer","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2011.07.001_bb0295","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.neuron.2005.03.025","article-title":"Pathological cell\u2013cell interactions elicited by a neuropathogenic form of mutant Huntingtin contribute to cortical pathogenesis in HD mice","volume":"46","author":"Gu","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2011.07.001_bb0300","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-1326-2-8","article-title":"Pathological cell\u2013cell interactions are necessary for striatal pathogenesis in a conditional mouse model of Huntington's disease","volume":"2","author":"Gu","year":"2007","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2011.07.001_bb0305","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.neuron.2006.07.012","article-title":"RGS2 determines short-term synaptic plasticity in hippocampal neurons by regulating Gi\/o-mediated inhibition of presynaptic Ca2+ channels","volume":"51","author":"Han","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2011.07.001_bb0310","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0006-291X(02)00498-9","article-title":"Ultrastructure of nuclear aggregates formed by expressing an expanded polyglutamine","volume":"294","author":"Hazeki","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.nbd.2011.07.001_bb0315","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.tig.2006.07.010","article-title":"Transcriptional alterations and chromatin remodeling in polyglutamine diseases","volume":"22","author":"Helmlinger","year":"2006","journal-title":"Trends Genet."},{"key":"10.1016\/j.nbd.2011.07.001_bb0320","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1073\/pnas.0437870100","article-title":"Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease","volume":"100","author":"Hockly","year":"2003","journal-title":"Proc.Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.07.001_bb0325","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/hmg\/ddl013","article-title":"Regional and cellular gene expression changes in human Huntington's disease brain","volume":"15","author":"Hodges","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.07.001_bb0330","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1601-183X.2007.00350.x","article-title":"Brain gene expression correlates with changes in behavior in the R6\/1 mouse model of Huntington's disease","volume":"7","author":"Hodges","year":"2008","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.nbd.2011.07.001_bb0335","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1073\/pnas.98.4.1811","article-title":"The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis","volume":"98","author":"Holbert","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.07.001_bb0340","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cell.2004.09.016","article-title":"PGC-1alpha: turbocharging mitochondria","volume":"119","author":"Houten","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2011.07.001_bb0345","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/B:SCAM.0000007124.19463.e5","article-title":"Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins","volume":"24","author":"Huang","year":"1998","journal-title":"Somat. Cell Mol. Genet."},{"key":"10.1016\/j.nbd.2011.07.001_bb0350","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group","volume":"72","author":"Huntington's Disease Collaborative Research Group, T.","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2011.07.001_bb0355","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/00001756-200303240-00007","article-title":"Inducible PC12 cell model of Huntington's disease shows toxicity and decreased histone acetylation","volume":"14","author":"Igarashi","year":"2003","journal-title":"Neuroreport"},{"key":"10.1016\/j.nbd.2011.07.001_bb0360","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/jnr.21881","article-title":"DNA breakage and induction of DNA damage response proteins precede the appearance of visible mutant huntingtin aggregates","volume":"87","author":"Illuzzi","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2011.07.001_bb0365","doi-asserted-by":"crossref","first-page":"7178","DOI":"10.1523\/JNEUROSCI.18-18-07178.1998","article-title":"Dynamic regulation of RGS2 suggests a novel mechanism in G-protein signaling and neuronal plasticity","volume":"18","author":"Ingi","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.07.001_bb0370","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0378-1119(00)00437-6","article-title":"Genomic organization and alternative transcripts of the human PQBP-1 gene","volume":"259","author":"Iwamoto","year":"2000","journal-title":"Gene"},{"issue":"14","key":"10.1016\/j.nbd.2011.07.001_bb0375","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1093\/hmg\/ddr195","article-title":"HD CAG-correlated gene expression changes support a simple dominant gain of function","volume":"20","author":"Jacobsen","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.07.001_bb0380","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1523\/JNEUROSCI.19-11-04189.1999","article-title":"Characterization of MALS\/Velis-1, -2, and -3: a family of mammalian LIN-7 homologs enriched at brain synapses in association with the postsynaptic density-95\/NMDA receptor postsynaptic complex","volume":"19","author":"Jo","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.07.001_bb0385","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12017-009-8063-4","article-title":"Gene dysregulation in Huntington's disease: REST, microRNAs and beyond","volume":"11","author":"Johnson","year":"2009","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.nbd.2011.07.001_bb0390","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.nbd.2007.11.001","article-title":"A microRNA-based gene dysregulation pathway in Huntington's disease","volume":"29","author":"Johnson","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.07.001_bb0395","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1371\/journal.pgen.0030082","article-title":"Huntingtin interacting proteins are genetic modifiers of neurodegeneration","volume":"3","author":"Kaltenbach","year":"2007","journal-title":"PLoS Genet."},{"key":"10.1016\/j.nbd.2011.07.001_bb0400","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/nrd2681","article-title":"Therapeutic application of histone deacetylase inhibitors for central nervous system disorders","volume":"7","author":"Kazantsev","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.nbd.2011.07.001_bb0405","doi-asserted-by":"crossref","first-page":"11404","DOI":"10.1073\/pnas.96.20.11404","article-title":"Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells","volume":"96","author":"Kazantsev","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.07.001_bb0410","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/ng864","article-title":"A bivalent Huntingtin binding peptide suppresses polyglutamine aggregation and pathogenesis in Drosophila","volume":"30","author":"Kazantsev","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2011.07.001_bb0415","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.1074\/jbc.M103946200","article-title":"Huntingtin is present in the nucleus, interacts with the transcriptional corepressor C-terminal binding protein, and represses transcription","volume":"277","author":"Kegel","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.07.001_bb0420","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1523\/JNEUROSCI.5667-07.2008","article-title":"Altered histone monoubiquitylation mediated by mutant huntingtin induces transcriptional dysregulation","volume":"28","author":"Kim","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.07.001_bb0425","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1471-4159.2005.03035.x","article-title":"Decreased expression of hypothalamic neuropeptides in Huntington disease transgenic mice with expanded polyglutamine-EGFP fluorescent aggregates","volume":"93","author":"Kotliarova","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2011.07.001_bb0430","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/hmg\/ddm133","article-title":"Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage","volume":"16","author":"Kuhn","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.07.001_bb0435","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1172\/JCI57413","article-title":"Altered chromatin architecture underlies progressive impairment of the heat shock response in mouse models of Huntington disease","volume":"121","author":"Labbadia","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2011.07.001_bb0440","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/sj.embor.7400250","article-title":"Huntingtin and the molecular pathogenesis of Huntington's disease. Fourth in molecular medicine review series","volume":"5","author":"Landles","year":"2004","journal-title":"EMBO Rep."},{"key":"10.1016\/j.nbd.2011.07.001_bb0445","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.brainres.2010.04.002","article-title":"MicroRNAs in neural cell differentiation","volume":"1338","author":"Lau","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2011.07.001_bb0450","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1371\/journal.pgen.0030135","article-title":"Unbiased gene expression analysis implicates the huntingtin polyglutamine tract in extra-mitochondrial energy metabolism","volume":"3","author":"Lee","year":"2007","journal-title":"PLoS Genet."},{"key":"10.1016\/j.nbd.2011.07.001_bb0455","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.expneurol.2010.10.012","article-title":"Altered microRNA regulation in Huntington's disease models","volume":"227","author":"Lee","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.07.001_bb0460","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1128\/MCB.22.5.1277-1287.2002","article-title":"Interaction of Huntington disease protein with transcriptional activator Sp1","volume":"22","author":"Li","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.nbd.2011.07.001_bb0465","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cell.2004.09.013","article-title":"Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice","volume":"119","author":"Lin","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2011.07.001_bb0470","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ddmec.2007.10.002","article-title":"Huntington's and other polyglutamine diseases: many effects of single gene mutations","volume":"4","author":"Luthi-Carter","year":"2007","journal-title":"Drug Discov Today Dis. Mech."},{"key":"10.1016\/j.nbd.2011.07.001_bb0475","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1566-2772(03)00059-8","article-title":"Mechanisms of transcriptional dysregulation in Huntington's disease","volume":"3","author":"Luthi-Carter","year":"2003","journal-title":"Clin. Neurosci. Res."},{"key":"10.1016\/j.nbd.2011.07.001_bb0480","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/hmg\/9.9.1259","article-title":"Decreased expression of striatal signaling genes in a mouse model of Huntington's disease","volume":"9","author":"Luthi-Carter","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.07.001_bb0485","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/hmg\/11.17.1911","article-title":"Dysregulation of gene expression in the R6\/2 model of polyglutamine disease: parallel changes in muscle and brain","volume":"11","author":"Luthi-Carter","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.07.001_bb0490","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/hmg\/11.17.1927","article-title":"Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects","volume":"11","author":"Luthi-Carter","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.07.001_bb0495","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.nbd.2003.08.024","article-title":"Complex alteration of NMDA receptors in transgenic Huntington's disease mouse brain: analysis of mRNA and protein expression, plasma membrane association, interacting proteins, and phosphorylation","volume":"14","author":"Luthi-Carter","year":"2003","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.07.001_bb0500","doi-asserted-by":"crossref","first-page":"7927","DOI":"10.1073\/pnas.1002924107","article-title":"SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis","volume":"107","author":"Luthi-Carter","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.07.001_bb0505","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1523\/JNEUROSCI.5113-06.2007","article-title":"Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington's disease","volume":"27","author":"Lynch","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.07.001_bb0510","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/hmg\/ddq460","article-title":"ERK activation by the polyphenols fisetin and resveratrol provides neuroprotection in multiple models of Huntington's disease","volume":"20","author":"Maher","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.07.001_bb0515","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.bmcl.2008.12.097","article-title":"Identification of 4-hydroxyquinolines inhibitors of p300\/CBP histone acetyltransferases","volume":"19","author":"Mai","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.nbd.2011.07.001_bb0520","doi-asserted-by":"crossref","first-page":"7219","DOI":"10.1093\/nar\/gkq575","article-title":"A myriad of miRNA variants in control and Huntington's disease brain regions detected by massively parallel sequencing","volume":"38","author":"Marti","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.nbd.2011.07.001_bb0525","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1093\/hmg\/9.14.2197","article-title":"CREB-binding protein sequestration by expanded polyglutamine","volume":"9","author":"McCampbell","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.07.001_bb0530","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/emmm.201000084","article-title":"Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington disease","volume":"2","author":"McConoughey","year":"2010","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.nbd.2011.07.001_bb0535","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.brainres.2010.03.035","article-title":"MicroRNA dysregulation in psychiatric disease","volume":"1338","author":"Miller","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2011.07.001_bb0540","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1093\/hmg\/ddl092","article-title":"Early development of aberrant synaptic plasticity in a mouse model of Huntington's disease","volume":"15","author":"Milnerwood","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.07.001_bb0545","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1460-9568.2005.03895.x","article-title":"A combination drug therapy improves cognition and reverses gene expression changes in a mouse model of Huntington's disease","volume":"21","author":"Morton","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2011.07.001_bb0550","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.nbd.2008.11.015","article-title":"Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6\/2 mice","volume":"33","author":"Morton","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.07.001_bb0555","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1021\/bi00429a006","article-title":"Ubiquitinated histone H2B is preferentially located in transcriptionally active chromatin","volume":"28","author":"Nickel","year":"1989","journal-title":"Biochemistry"},{"key":"10.1016\/j.nbd.2011.07.001_bb0560","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1385\/MN:30:3:307","article-title":"Nuclear receptor coregulators are new players in nervous system development and function","volume":"30","author":"Nishihara","year":"2004","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2011.07.001_bb0565","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1126\/science.1056784","article-title":"Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity","volume":"291","author":"Nucifora","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.nbd.2011.07.001_bb0570","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1523\/JNEUROSCI.3493-03.2004","article-title":"CRE-mediated transcription is increased in Huntington's disease transgenic mice","volume":"24","author":"Obrietan","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.07.001_bb0575","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0896-6273(02)00697-9","article-title":"Interaction between mutant ataxin-1 and PQBP-1 affects transcription and cell death","volume":"34","author":"Okazawa","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2011.07.001_bb0580","doi-asserted-by":"crossref","first-page":"14341","DOI":"10.1523\/JNEUROSCI.2390-08.2008","article-title":"The bifunctional microRNA miR-9\/miR-9* regulates REST and CoREST and is downregulated in Huntington's disease","volume":"28","author":"Packer","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.07.001_bb0585","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1093\/hmg\/ddn273","article-title":"Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington's disease","volume":"17","author":"Pallos","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.07.001_bb0590","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.molcel.2007.05.001","article-title":"Argonaute proteins: mediators of RNA silencing","volume":"26","author":"Peters","year":"2007","journal-title":"Mol Cell."},{"key":"10.1016\/j.nbd.2011.07.001_bb0595","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/hmg\/ddn428","article-title":"Adipose tissue dysfunction tracks disease progression in two Huntington's disease mouse models","volume":"18","author":"Phan","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.07.001_bb0600","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11302-007-9066-y","article-title":"Adenosine A(2A) receptors modulate BDNF both in normal conditions and in experimental models of Huntington's disease","volume":"3","author":"Potenza","year":"2007","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.nbd.2011.07.001_bb0605","doi-asserted-by":"crossref","first-page":"16672","DOI":"10.1074\/jbc.M511648200","article-title":"Sp1 is up-regulated in cellular and transgenic models of Huntington disease, and its reduction is neuroprotective","volume":"281","author":"Qiu","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.07.001_bb0610","first-page":"2","article-title":"Evaluation of histone deacetylases as drug targets in Huntington's disease models. Study of HDACs in brain tissues from R6\/2 and CAG140 knock-in HD mouse models and human patients and in a neuronal HD cell model","author":"Quinti","year":"2010","journal-title":"PLoS Curr."},{"key":"10.1016\/j.nbd.2011.07.001_bb0615","doi-asserted-by":"crossref","first-page":"e14311","DOI":"10.1371\/journal.pone.0014311","article-title":"Transcriptional activation of REST by Sp1 in Huntington's disease models","volume":"5","author":"Ravache","year":"2010","journal-title":"PLoS One."},{"key":"10.1016\/j.nbd.2011.07.001_bb0620","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.2174\/1389450111007011262","article-title":"The role of PGC-1alpha in the pathogenesis of neurodegenerative disorders","volume":"11","author":"Rona-Voros","year":"2010","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.nbd.2011.07.001_bb0625","series-title":"Diminished hippocalcin expression in Huntington's disease (HD) brain does not account for increased striatal neuron vulnerability as assessed in primary neuron models of HD","author":"Rudinskiy","year":"2009"},{"key":"10.1016\/j.nbd.2011.07.001_bb0630","doi-asserted-by":"crossref","first-page":"14424","DOI":"10.1073\/pnas.0703652104","article-title":"Analysis of potential transcriptomic biomarkers for Huntington's disease in peripheral blood","volume":"104","author":"Runne","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.07.001_bb0635","doi-asserted-by":"crossref","first-page":"9723","DOI":"10.1523\/JNEUROSCI.3044-08.2008","article-title":"Dysregulation of gene expression in primary neuron models of Huntington's disease shows that polyglutamine-related effects on the striatal transcriptome may not be dependent on brain circuitry","volume":"28","author":"Runne","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.07.001_bb0640","doi-asserted-by":"crossref","first-page":"19176","DOI":"10.1073\/pnas.0606373103","article-title":"ESET\/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease","volume":"103","author":"Ryu","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.07.001_bb0645","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2174\/156720506778249407","article-title":"Histone deacetylase inhibitors: a novel therapeutic approach to Huntington's disease (complex mechanism of neuronal death)","volume":"3","author":"Sadri-Vakili","year":"2006","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.nbd.2011.07.001_bb0650","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/hmg\/ddm078","article-title":"Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models","volume":"16","author":"Sadri-Vakili","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.07.001_bb0655","doi-asserted-by":"crossref","first-page":"15842","DOI":"10.1074\/jbc.M210663200","article-title":"Identification of RGS2 and type V adenylyl cyclase interaction sites","volume":"278","author":"Salim","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.07.001_bb0660","doi-asserted-by":"crossref","first-page":"10820","DOI":"10.1073\/pnas.0800658105","article-title":"Huntington's disease protein contributes to RNA-mediated gene silencing through association with Argonaute and P bodies","volume":"105","author":"Savas","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.07.001_bb0665","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/nrn2763","article-title":"microRNAs at the synapse","volume":"10","author":"Schratt","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2011.07.001_bb0670","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1371\/journal.pone.0000238","article-title":"Proteasome activator enhances survival of Huntington's disease neuronal model cells","volume":"2","author":"Seo","year":"2007","journal-title":"PLoS One."},{"key":"10.1016\/j.nbd.2011.07.001_bb0675","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/hmg\/ddp524","article-title":"Huntingtin facilitates polycomb repressive complex 2","volume":"19","author":"Seong","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.07.001_bb0680","doi-asserted-by":"crossref","first-page":"e22231","DOI":"10.1371\/journal.pone.0022231","article-title":"Decreased Striatal RGS2 Expression Is Neuroprotective in Huntington's Disease (HD) and Exemplifies a Compensatory Aspect of HD-Induced Gene Regulation","volume":"6","author":"Seredenina","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2011.07.001_bb0685","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/79139","article-title":"Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription","volume":"26","author":"Shimohata","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2011.07.001_bb0690","doi-asserted-by":"crossref","first-page":"34880","DOI":"10.1074\/jbc.M804183200","article-title":"Huntingtin regulates RE1-silencing transcription factor\/neuron-restrictive silencer factor (REST\/NRSF) nuclear trafficking indirectly through a complex with REST\/NRSF-interacting LIM domain protein (RILP) and dynactin p150 Glued","volume":"283","author":"Shimojo","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.07.001_bb0695","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.bbrc.2010.05.007","article-title":"Altered microRNAs in STHdh(Q111)\/Hdh(Q111) cells: miR-146a targets TBP","volume":"396","author":"Sinha","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.nbd.2011.07.001_bb0700","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/35059104","article-title":"RGS2 regulates signal transduction in olfactory neurons by attenuating activation of adenylyl cyclase III","volume":"409","author":"Sinnarajah","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2011.07.001_bb0705","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/hmg\/11.17.1953","article-title":"Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses","volume":"11","author":"Sipione","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.07.001_bb0710","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1517\/13543780902810345","article-title":"Putting the \u2018HAT\u2019 back on survival signalling: the promises and challenges of HDAC inhibition in the treatment of neurological conditions","volume":"18","author":"Sleiman","year":"2009","journal-title":"Expert. Opin. Investig. Drugs."},{"key":"10.1016\/j.nbd.2011.07.001_bb0715","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/hmg\/ddm064","article-title":"Modulation of nucleosome dynamics in Huntington's disease","volume":"16","author":"Stack","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.07.001_bb0720","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1073\/pnas.100110097","article-title":"The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription","volume":"97","author":"Steffan","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.07.001_bb0725","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/35099568","article-title":"Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila","volume":"413","author":"Steffan","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2011.07.001_bb0730","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1093\/hmg\/ddi192","article-title":"Gene expression in Huntington's disease skeletal muscle: a potential biomarker","volume":"14","author":"Strand","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.07.001_bb0735","doi-asserted-by":"crossref","first-page":"11758","DOI":"10.1523\/JNEUROSCI.2461-07.2007","article-title":"Expression profiling of Huntington's disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration","volume":"27","author":"Strand","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.07.001_bb0740","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/hmg\/ddl467","article-title":"Wild-type huntingtin participates in protein trafficking between the Golgi and the extracellular space","volume":"16","author":"Strehlow","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.07.001_bb0745","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1126\/science.1172871","article-title":"Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity","volume":"324","author":"Subramaniam","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.nbd.2011.07.001_bb0750","doi-asserted-by":"crossref","first-page":"20428","DOI":"10.1074\/jbc.C110.127191","article-title":"Rhes, a physiologic regulator of sumoylation, enhances cross-sumoylation between the basic sumoylation enzymes E1 and Ubc9","volume":"285","author":"Subramaniam","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.07.001_bb0755","doi-asserted-by":"crossref","first-page":"4988","DOI":"10.1074\/jbc.M310226200","article-title":"Decreased cAMP response element-mediated transcription: an early event in exon 1 and full-length cell models of Huntington's disease that contributes to polyglutamine pathogenesis","volume":"279","author":"Sugars","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.07.001_bb0760","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1083\/jcb.153.2.283","article-title":"Identities of sequestered proteins in aggregates from cells with induced polyglutamine expression","volume":"153","author":"Suhr","year":"2001","journal-title":"J. Cell. Biol."},{"key":"10.1016\/j.nbd.2011.07.001_bb0765","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1750-1326-4-10","article-title":"PGC-1alpha as modifier of onset age in Huntington disease","volume":"4","author":"Taherzadeh-Fard","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2011.07.001_bb0770","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2202-3-15","article-title":"The predominantly HEAT-like motif structure of huntingtin and its association and coincident nuclear entry with dorsal, an NF-kB\/Rel\/dorsal family transcription factor","volume":"3","author":"Takano","year":"2002","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.nbd.2011.07.001_bb0775","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.nbd.2011.02.008","article-title":"Gene expression profiling of R6\/2 transgenic mice with different CAG repeat lengths reveals genes associated with disease onset and progression in Huntington's disease","volume":"42","author":"Tang","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.07.001_bb0780","doi-asserted-by":"crossref","first-page":"15564","DOI":"10.1073\/pnas.0804249105","article-title":"The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice","volume":"105","author":"Thomas","year":"2008","journal-title":"Proc. Natl. Acad. Sc.i U. S. A."},{"key":"10.1016\/j.nbd.2011.07.001_bb0785","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/hmg\/ddq548","article-title":"In vivo cell-autonomous transcriptional abnormalities revealed in mice expressing mutant huntingtin in striatal but not cortical neurons","volume":"20","author":"Thomas","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.07.001_bb0790","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/brain\/awq047","article-title":"Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington's disease","volume":"133","author":"Thu","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2011.07.001_bb0795","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/hmg\/8.5.839","article-title":"Impaired synaptic plasticity in mice carrying the Huntington's disease mutation","volume":"8","author":"Usdin","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.07.001_bb0800","doi-asserted-by":"crossref","first-page":"5850","DOI":"10.1128\/MCB.24.13.5850-5862.2004","article-title":"Functional interaction of monoubiquitinated FANCD2 and BRCA2\/FANCD1 in chromatin","volume":"24","author":"Wang","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.nbd.2011.07.001_bb0805","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/hmg\/8.6.977","article-title":"PQBP-1, a novel polyglutamine tract-binding protein, inhibits transcription activation by Brn-2 and affects cell survival","volume":"8","author":"Waragai","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.07.001_bb0810","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cmet.2006.10.004","article-title":"Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration","volume":"4","author":"Weydt","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.nbd.2011.07.001_bb0815","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1750-1326-4-3","article-title":"The gene coding for PGC-1 modifies age at onset in Huntington's disease","volume":"4","author":"Weydt","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2011.07.001_bb0820","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/hmg\/11.6.633","article-title":"Early phenotypes that presage late-onset neurodegenerative disease allow testing of modifiers in Hdh CAG knock-in mice","volume":"11","author":"Wheeler","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.07.001_bb0825","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/385439a0","article-title":"Competitive binding of alpha-actinin and calmodulin to the NMDA receptor","volume":"385","author":"Wyszynski","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2011.07.001_bb0830","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/hmg\/10.17.1829","article-title":"Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease","volume":"10","author":"Wyttenbach","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.07.001_bb0835","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/emboj.2008.23","article-title":"Mutant huntingtin reduces HSP70 expression through the sequestration of NF-Y transcription factor","volume":"27","author":"Yamanaka","year":"2008","journal-title":"EMBO J."},{"key":"10.1016\/j.nbd.2011.07.001_bb0840","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1093\/hmg\/ddq087","article-title":"Mutant huntingtin fragment selectively suppresses Brn-2 POU domain transcription factor to mediate hypothalamic cell dysfunction","volume":"19","author":"Yamanaka","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.07.001_bb0845","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S1044-7431(03)00032-0","article-title":"Mutant huntingtin increases nuclear corepressor function and enhances ligand-dependent nuclear hormone receptor activation","volume":"23","author":"Yohrling","year":"2003","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2011.07.001_bb0850","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.cell.2005.10.030","article-title":"In vitro analysis of huntingtin-mediated transcriptional repression reveals multiple transcription factor targets","volume":"123","author":"Zhai","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2011.07.001_bb0855","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1471-2202-9-38","article-title":"Elucidating a normal function of huntingtin by functional and microarray analysis of huntingtin-null mouse embryonic fibroblasts","volume":"9","author":"Zhang","year":"2008","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.nbd.2011.07.001_bb0860","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease","volume":"293","author":"Zuccato","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.nbd.2011.07.001_bb0865","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ng1219","article-title":"Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes","volume":"35","author":"Zuccato","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2011.07.001_bb0870","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.phrs.2005.01.001","article-title":"Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery","volume":"52","author":"Zuccato","year":"2005","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.nbd.2011.07.001_bb0875","doi-asserted-by":"crossref","first-page":"6972","DOI":"10.1523\/JNEUROSCI.4278-06.2007","article-title":"Widespread disruption of repressor element-1 silencing transcription factor\/neuron-restrictive silencer factor occupancy at its target genes in Huntington's disease","volume":"27","author":"Zuccato","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.07.001_bb0880","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1750-3639.2007.00111.x","article-title":"Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington's disease","volume":"18","author":"Zuccato","year":"2008","journal-title":"Brain Pathol."},{"key":"10.1016\/j.nbd.2011.07.001_bb0885","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/hmg\/ddi014","article-title":"Transcriptional dysregulation in striatal projection- and interneurons in a mouse model of Huntington's disease: neuronal selectivity and potential neuroprotective role of HAP1","volume":"14","author":"Zucker","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.07.001_bb0890","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/NEN.0b013e3181ed7a41","article-title":"Decreased Lin7b expression in layer 5 pyramidal neurons may contribute to impaired corticostriatal connectivity in Huntington disease","volume":"69","author":"Zucker","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996111002270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996111002270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T14:41:03Z","timestamp":1714660863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996111002270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":180,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0969996111002270"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2011.07.001","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What have we learned from gene expression profiles in Huntington's disease?","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2011.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}